Terapia prechirurgica della fibromatosi uterina - FedOA - Università ...

More documents

Recommendations

Info

85. Yang CH, Lee JN, Hsu SC, Kuo CH, Tsai EM. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women: a 3- year study. Maturitas 2002;43(1):35-9 86. Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 1997; 3:27-45 87. Ignotz RA, Massague J. Transforming growth factor-B stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261:4337-45 88. Bruner KL, Rodgers WH, Gold LI, Kore M, Hargrove JT, Matrisian LM et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Nat Acad Sci USA 1995; 92:7362-6 89. Ma C, Chegini N. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-β1. Mol Hum Reprod 1999; 5:950-4 90. Derynck R, Lindquist PB, Lee A, Wen D, Tamm J, Graycar IL et al. A new type of transforming growth factor-β, TGF-β3. EMBO J 1988; 7:3737-43 131
91. Arici A, Sozen I. Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 2000; 73:1006-11 92. Chegini N, Ma C, Tang XM, Williams RS. Effects of GnRH analogues, “add-back” steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 2002; 8(12):1071-8 93. Dou Q, Tamuzzer RW, Williams RS, Schultz GS, Chegini N. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotropin releasing hormone agonist-induced tumor regression. Mol Hum Reprod 1997; 3:1005-14. 94. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 1996; 81(9):3222-30. 132
Page 2 and 3:
INDICE Introduzione……………
Page 4 and 5:
Introduzione La fibromatosi uterina
Page 6 and 7:
La fibromatosi uterina: eziopatogen
Page 8 and 9:
antigen), indicatore di proliferazi
Page 10 and 11:
egressione e vasi neoformati invado
Page 12 and 13:
laparoisterectomia totale; tuttavia
Page 14 and 15:
fibromatosi uterina. Attraverso la
Page 16 and 17:
legame per i recettori degli steroi
Page 18 and 19:
esecuzione della tecnica sono rare,
Page 20 and 21:
In condizioni patologiche, invece,
Page 22 and 23:
I leiomiomi uterini, come precedent
Page 24 and 25:
il bFGF è immagazzinato in forma i
Page 26 and 27:
per PDGF, bFGF e VEGF, sia nelle ce
Page 28 and 29:
iportato un decremento della prolif
Page 30 and 31:
Terapia prechirurgica della fibroma
Page 32 and 33:
Gli effetti del TGF-β sembrano ess
Page 34 and 35:
contribuire anche ad approfondire l
Page 36 and 37:
Entro tre settimane dall’ultima s
Page 38 and 39:
0.5 cm dal mioma (nella maggior par
Page 40 and 41:
cellule presenti nei 10 campi. Quin
Page 42 and 43:
isultati simili in entrambi i grupp
Page 44 and 45:
Il numero di vampate di calore è a
Page 46 and 47:
Figura 1. Numero medio mensile di v
Page 48 and 49:
valori corrispondenti alle categori
Page 50 and 51:
Figura 3. a) Un caso di leiomioma n
Page 52 and 53:
Discussione e conclusioni I dati ri
Page 54 and 55:
terapia con GnRH-a o con GnRH-a e t
Page 56 and 57:
endoteliali che nelle fibrocellule
Page 58 and 59:
uterini e nel miometrio e supporta
Page 60:
CTGF. 12 th World Congress of Gynec
Page 74 and 75:
miometrio immediatamente circostant
Page 76 and 77:
Materiali e metodi Lo studio è sta
Page 78 and 79:
vasocostrittori. I chirurghi non er
Page 80 and 81:
quanto riguarda la valutazione vasc
Page 82 and 83: Risultati In accordo con valutazion
Page 84 and 85: Tabella 3. Diametro del leiomioma e
Page 86 and 87: Figura 5. a) Percentuale moderata-a
Page 88 and 89: Per la prima volta in letteratura,
Page 90 and 91: Un ridotto trofismo tissutale dovut
Page 92 and 93: Pubblicazioni I risultati del secon
Page 94 and 95: Leiomyoma pseudocapsule after pre-s
Page 96 and 97: Leiomyoma pseudocapsule after pre-s
Page 98 and 99: Materials and methods Thirty-three
Page 100 and 101: Italy). For that concerning the vas
Page 102 and 103: Comment Uterine leiomyomas are surr
Page 104 and 105: pseudocapsule zone could explain, a
Page 106 and 107: References 1) Lethaby A, Vollenhove
Page 108 and 109: Table 1. Leiomyoma diameter and hae
Page 110 and 111: Figure 2. a) Moderate to high perce
Page 112 and 113: 111
Page 114 and 115: 113
Page 116 and 117: 115
Page 118 and 119: 6. Battista S, Fidanza V, Fedele M,
Page 120 and 121: hormone analog-treated uterine leio
Page 122 and 123: 27. Rannestad T, Eikeland O, Hellan
Page 124 and 125: 40. Di Lieto A, De Falco M, Staiban
Page 126 and 127: 49. Spies JB, Warren EH, Mathias SD
Page 128 and 129: for the neovascularization of norma
Page 130 and 131: premenopausal women with uterine fi
Page 134 and 135: 95. Pawar S, Kartha S, Toback FG. D
Page 136 and 137: 106. Weston G, Trajstman AC, Garget
Page 138 and 139: abdominal myomectomy: a controlled
Page 140 and 141: della Società Italiana di Ginecolo
Page 142 and 143: 11. Pollio F, De Falco M, Di Nardo
Page 144 and 145: Italiana di Ginecologia e Ostetrici
Page 146 and 147: considerazioni cliniche ed immunois
Page 148 and 149: 147
Page 150 and 151: 149
Page 152 and 153: 151
Page 154 and 155: 153
Page 156 and 157: 155
Page 158 and 159: 157
Page 160 and 161: 159
Page 162 and 163: 161
Page 164 and 165: 163
Page 166 and 167: 165
Page 168 and 169: 167
Page 170 and 171: 169
Page 172 and 173: 171
Page 174 and 175: 173
Page 176 and 177: 175
Page 178 and 179: 177
Page 180 and 181: 179
Page 182 and 183:
181
Page 184 and 185:
183
Page 186 and 187:
185
Page 188 and 189:
187
Page 190 and 191:
189
Page 192 and 193:
191
Page 194 and 195:
193
Page 196 and 197:
195
Page 198 and 199:
197
Page 200 and 201:
199
Page 202 and 203:
201
Page 204 and 205:
203
Page 206 and 207:
205
Page 208 and 209:
207
Page 210 and 211:
209
Page 212 and 213:
211
Page 214 and 215:
213
Page 216 and 217:
215
Page 218 and 219:
217
Page 220 and 221:
219
Page 222 and 223:
221
Page 224 and 225:
223
Page 226 and 227:
225
Page 228 and 229:
227
Page 230 and 231:
229
Page 232 and 233:
231
Page 234 and 235:
233
Page 236 and 237:
235
Page 238 and 239:
237
show all

Terapia prechirurgica della fibromatosi uterina - FedOA - Università ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?